Screener
Xenon Pharmaceuticals XENE Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Xenon Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338244
FAQ
- What is Xenon Pharmaceuticals's operating margin?
- Xenon Pharmaceuticals (XENE) reported operating margin of -4,974.3% in Q4 2025.
- What is the long-term trend for Xenon Pharmaceuticals's operating margin?
- Over 3 years (2020 to 2025), Xenon Pharmaceuticals's operating margin has grown at a 271.1% compound annual growth rate (CAGR), from -97.3% to -4,974.3%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.
Ask your AI about Xenon Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude